In murine xenograft tumor models, lipoxin A4 is able to suppress tumor growth by targeting immune-suppressive IL-10-producing regulatory B cells via dephosphorylation of STAT-3 and extracellular signal-regulated kinase (59). This evidence concerns the gene IL10 and neoplasm.